Clopidogrel in combination with aspirin reduces the number of events related to percutaneous coronary intervention (PCI) in patients with stable coronary artery disease (CAD), and is the recommended ...
NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of ...